文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

阴道微生物群与人乳头瘤病毒、沙眼衣原体、淋病奈瑟菌及生殖支原体感染关联的系统综述与Meta分析

The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis.
PubMed 文献 · Clin Microbiol Infect · 2018-05-03

该系统综述与Meta分析检索2000至2016年Medline和Web of Science文献,纳入39项研究,评估阴道微生物群与HPV、沙眼衣原体、淋病奈瑟菌及生殖支原体感染的关联。结果显示高乳酸杆菌阴道微生物群对HPV和沙眼衣原体感染具有保护作用,淋病奈瑟菌和生殖支原体感染未检测到明确趋势。

要点

  • 高乳酸杆菌阴道微生物群对HPV和沙眼衣原体感染具有保护作用。
  • 淋病奈瑟菌和生殖支原体感染与阴道微生物群的关联未检测到明确趋势。
  • 作者主张采用高分辨率阴道微生物群表征方法并开展纵向研究。

核心结论

  • 虽然淋病奈瑟菌和生殖支原体感染未检测到明确趋势,但结果支持高乳酸杆菌阴道微生物群对HPV和沙眼衣原体感染具有保护作用。
  • 作者主张采用高分辨率阴道微生物群表征方法,并需要纵向研究为其纳入预防和治疗策略奠定基础。

研究设计与样本

  • 系统综述与Meta分析,检索Medline和Web of Science 2000至2016年发表的文献。
  • 纳入标准包括:提供阴道微生物群与所考虑性传播感染之一的关联测量、女性人群、队列/横断面/干预设计、使用PCR方法检测病原体。
  • 检索共获得1054篇文章,其中39篇符合纳入标准。
  • 阴道微生物群通过Nugent评分、Amsel标准、线索细胞存在或基因测序二分为高乳酸杆菌阴道微生物群(HL-VMB)和低乳酸杆菌阴道微生物群(LL-VMB)。
  • 对每种性传播感染采用随机效应模型,假设研究间存在异质性。

主要发现

  • 与LL-VMB的关联测量值范围:HPV感染为0.6(95%CI 0.3-1.2)至2.8(95%CI 0.3-28.0)。
  • 与LL-VMB的关联测量值范围:沙眼衣原体感染为0.7(95%CI 0.4-1.2)至5.2(95%CI 1.9-14.8)。
  • 与LL-VMB的关联测量值范围:淋病奈瑟菌感染为0.8(95%CI 0.5-1.4)至3.8(95%CI 0.4-36.2)。
  • 与LL-VMB的关联测量值范围:生殖支原体感染为0.4(95%CI 0.1-1.5)至6.1(95%CI 2.0-18.5)。

临床怎么用

  • 作者主张采用高分辨率阴道微生物群表征方法。
  • 作者认为需要纵向研究为阴道微生物群纳入预防和治疗策略奠定基础。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The vaginal microbiota may modulate susceptibility to human papillomavirus (HPV), Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections. Persistent infection with a carcinogenic HPV is a prerequisite for cervical cancer, and C. trachomatis, N. gonorrheae and M. genitalium genital infections are all associated with pelvic inflammatory disease and subsequent infertility issues. OBJECTIVES: To evaluate the association between these infections and the vaginal microbiota. DATA SOURCES: The search was conducted on Medline and the Web of Science for articles published between 2000 and 2016. STUDY ELIGIBILITY CRITERIA: Inclusion criteria included a measure of association for vaginal microbiota and one of the considered STIs, female population, cohort, cross-sectional and interventional designs, and the use of PCR methods for pathogen detection. METHODS: The vaginal microbiota was dichotomized into high-Lactobacillus vaginal microbiota (HL-VMB) and low-Lactobacillus vaginal microbiota (LL-VMB), using either Nugent score, Amsel's criteria, presence of clue cells or gene sequencing. A random effects model assuming heterogeneity among the studies was used for each STI considered. RESULTS: The search yielded 1054 articles, of which 39 met the inclusion criteria. Measures of association with LL-VMB ranged from 0.6 (95% CI 0.3-1.2) to 2.8 (95% CI 0.3-28.0), 0.7 (95% CI 0.4-1.2) to 5.2 (95% CI 1.9-14.8), 0.8 (95% CI 0.5-1.4) to 3.8 (95% CI 0.4-36.2) and 0.4 (95% CI 0.1-1.5) to 6.1 (95% CI 2.0-18.5) for HPV, C. trachomatis, N. gonorrhoeae and M. genitalium infections, respectively. CONCLUSIONS: Although no clear trend for N. gonorrhoeae and M. genitalium infections could be detected, our results support a protective role of HL-VMB for HPV and C. trachomatis. Overall, these findings advocate for the use of high-resolution characterization methods for the vaginal microbiota and the need for longitudinal studies to lay the foundation for its integration in prevention and treatment strategies.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Tamarelle J, Thiébaut ACM, de Barbeyrac B, et al. The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis. Clin Microbiol Infect. 2018. PMID: 29729331. doi:10.1016/j.cmi.2018.04.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。